Due to a strong healthcare infrastructure and supportive healthcare policies, the adoption of wound care products is increasing in Germany. Increased investment in medical infrastructure will drive demand for synthetic hemostatic and wound care products in Japan
NEWARK, DE / ACCESSWIRE / October 28, 2024 / The global synthetic hemostasis and wound care products market is experiencing significant growth, with the market size expected to reach USD 7,327.1 million by 2024. Masu. Over the next 10 years, the market will grow at a compound annual growth rate (CAGR) of 4.5%, reaching a valuation of USD 11,325.6 million by 2034.
The demand for synthetic hemostatic and wound care products is driven by the steady increase in surgical procedures worldwide. The increase in road traffic injuries has also increased the need for effective hemorrhage control, especially in emergency situations. These factors are contributing significantly to the rapid expansion of the market.
Additionally, the industry is seeing a new trend in incorporating analgesics within wound dressings, providing a comprehensive solution that not only controls bleeding but also addresses pain management. This innovative approach improves patient comfort and optimizes the wound healing process, further driving market growth.
A wide range of synthetic hemostatic and wound care products are available to address a variety of medical needs, including:
These products address a variety of indications, from trauma and emergency care to chronic wounds, burns, and surgical applications. Its versatility in a variety of environments such as hospitals, emergency medical services, and military applications will ensure strong demand growth.
“Advances in synthetic wound care solutions are a testament to the healthcare industry’s commitment to innovation and improved patient outcomes. With the introduction of products that combine hemostatic and analgesic capabilities, the market is meeting both clinical needs and patient comfort. , we have been able to achieve continued growth,” said Sabyasachi Ghosh, Associate Vice President, Future Market Insights (FMI).
Market outlook:
The synthetic hemostasis and wound care products market is expected to maintain robust growth due to the expected increase in surgical procedures, traffic accidents, and the increasing burden of chronic wounds such as diabetes and pressure ulcers. Innovative solutions that combine bleeding control and pain management are advancing the industry and promising better outcomes for patients around the world.
As the global healthcare landscape continues to evolve, the synthetic hemostasis and wound care products market is at the forefront of medical innovation. With expected growth and advancements in product offerings, players in the healthcare sector are poised to benefit from the promising future of the market.
Key points from the provided text are:
The synthetic hemostatic and wound care products market was valued at USD 7,327.1 million in 2024.
This market is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2034.
By 2034, the market is expected to reach USD 11,325.6 million.
Regional market insights:
The following countries are expected to contribute significantly to the market growth:
Steady growth at US CAGR of 2.8%.
Germany Moderate growth with a CAGR of 2.4%.
China Strong growth with CAGR of 8.1%.
France Significant growth with CAGR of 6.2%.
Italy Moderate growth at CAGR 3.1%.
UK Slow growth with CAGR of 5.6%.
Japan Moderate growth with a CAGR of 5.1%.
India Strong growth with CAGR of 8.6%.
Canada Moderate growth at a CAGR of 4.3%.
Overall, the synthetic hemostasis and wound care products market is poised to witness significant growth due to factors such as aging population, increasing incidence of chronic wounds, and advancements in medical technology.
Competitive landscape of the synthetic hemostatic and wound care products industry:
Leading companies in the synthetic hemostasis and wound care products market are strategically acquiring smaller, innovative companies to take advantage of technological advances. These acquisitions not only expand the acquiring company’s product range, but also strengthen its position in the competitive environment. Additionally, companies are expanding their global footprint by establishing facilities in emerging markets, which improves product accessibility and accelerates market penetration.
Recent trends in the synthetic hemostasis and wound care products market
July 2024: Möllnlycke Healthcare makes a $15 million investment in MediWound Ltd. through a definitive stock purchase agreement, marking a significant private investment in public equity (PIPE).
September 2024: Tri-Tech Forensics acquires SAM Medical, expanding its range of emergency medical products and strengthening its market presence.
May 2024: Stryker opens a Customer Experience Center at its Global Technology Center in Gurgaon, India. This advanced facility is designed to showcase Stryker medical equipment and provide healthcare professionals with an interactive space to explore new technology, improve customer engagement, and address current challenges in care. I am.
Growing need for market insights: For thorough analysis and trends, access the full report:
https://www.futuremarketinsights.com/reports/synthetic-hemostatic-and-wound-care-products-market
Key players in the synthetic hemostasis and wound care products industry:
3M
Möllnlycke Healthcare
smith and nephew
johnson & johnson
Convatech Co., Ltd.
baxter international
coroplast
Paul Hartman AG
essence
striker
Roman & Rauscher (L&R)
Winner Medical Co., Ltd.
medtronic
teleflex company
Medtrade Products Co., Ltd.
zimmer biomet
Gende Medical Co., Ltd.
Market Segmentation for Synthetic Hemostasis and Wound Care Products:
By product:
In terms of products, the industry specializes in bleeding control bandages (Israeli bandages (emergency bandages), hemostatic bandages, compression bandages), tourniquet systems (mechanical tourniquets and pneumatic tourniquets), synthetic wound dressings (hydrogel bandages, semipermeable films) It is classified as bandages, foam bandages, hydrocolloid bandages, superabsorbent bandages, and other synthetic wound dressings), and hemostatic agents (powders/granules, sponges and pads, and matrix and gel hemostatic agents).
By material:
In terms of materials, the industry uses polyurethane, polyethylene glycol, nylon, spandex, synthetic rubber, polyvinyl alcohol (PVA), silicone, carboxymethylcellulose (CMC), sodium polyacrylate, recombinant proteins (thrombin), oxidized regenerated cellulose, and processed products. Divided. gelatin/collagen and other materials.
By indication:
In terms of indications, the industry is divided into trauma and emergency care, surgery, military applications, chronic wounds (diabetic ulcers, bedsores, etc.), burns and superficial wounds, and other indications.
By distribution channel:
In terms of distribution channels, the industry consists of institutional sales (hospitals, specialty clinics, wound care centers, ambulatory surgery centers, trauma care and emergency centers, home care and nursing care providers) and retail sales (pharmacies and online retail). .
By region:
The major countries in North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East and Africa are covered in this report.
author:
Sabyasachi Ghosh (Vice President, Future Market Insights, Inc.) has over 12 years of experience in the healthcare, medical device, and pharmaceutical industries. His curiosity and analytical skills helped shape his career as a researcher.
It comes naturally to him to identify the key challenges faced by his clients and develop robust, hypothesis-based solutions to empower them with strategic decision-making capabilities. His main expertise lies in the areas of market entry and expansion strategies, feasibility studies, competitive intelligence, and strategic transformation.
Sabyasachi, who holds a degree in microbiology, has written numerous publications and has been cited in journals such as The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s relevant and ongoing coverage of the Healthcare Market Insights domain.
The surgical stapling equipment market size is projected to be USD 3,977.4 million in 2023. The market research report anticipates a growth of USD 5,930.6 million by 2033. Surgical stapling equipment sales are anticipated to register a CAGR of 4.10% during the forecast period.
The Suture Anchor Devices market share is estimated to reach a valuation of USD 1,080.9 million by 2033. Our healthcare analysts predict that the suture anchor device maker can expect a CAGR of 4.2% by 2033, with a current valuation of USD 719.6 million in 2023.
The robot-assisted surgical microscope market demand is projected to be worth USD 410.6 million in 2023. The market is likely to exceed USD 858 million by 2033 at a CAGR of 7.6% during the forecast period.
The growth of the synthetic biology market is expected to rise from USD 3.75 billion in 2024 to USD 31.73 billion by 2034, growing favorably at a CAGR of 23.8% during the forecast period.
ePrescibing Market Trends is expected to grow at a CAGR of 27.1% during the forecast period. The market value is projected to increase from USD 4.8 billion in 2024 to USD 52.2 billion by 2034.
Pharmaceutical Manufacturing Equipment Market Overview: Expected to rise at a CAGR of 6.4% during the forecast period. The market value is projected to increase from $14.7 billion in 2024 to $27.3 billion by 2034.
The outlook for the medical exoskeleton market is estimated at USD 394.3 million in 2024. As the global population ages, there is a growing need for assistive exoskeletal devices for normal activities and rehabilitation. The market is projected to rise at a robust CAGR of 29.1% during the forecast period. The global medical exoskeleton industry share is estimated to reach nearly USD 5.1 billion by 2034.
The medical display market development is expected to be worth USD 4.3 billion by 2034. According to estimates, the market is expected to grow at a CAGR of 5.3% until 2034. The medical display market size in 2024 is estimated to be USD 2.6 billion.
The veterinary telemedicine market opportunity is estimated to reach a valuation of USD 145 million in 2024. It is projected to reach a valuation of USD 746 million by 2034, reflecting a CAGR of 17.8% over the assessment period.
The Cardiology Information Systems market forecast is estimated to be USD 1.3 billion in 2024. Cardiology information systems are projected to grow at a CAGR of 9.7% from 2024 to 2034. The global cardiac information systems market is expected to reach USD 3.7 billion by 2024. 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR Certified, Stevie Award Winner, Greater New York Chamber of Commerce Member) provides deep insight into the drivers driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting, and events for the packaging, food and beverage, consumer technology, healthcare, industrial, and chemical markets. FMI has a large team of more than 400 analysts worldwide, providing global, regional and local expertise on trends in diverse sectors and industries in more than 110 countries.
Please join us as we celebrate 10 years of providing trusted market insights. As we reflect on 10 years of accomplishments, we continue to lead with integrity, innovation and expertise.
inquiry:
Future Market Insights Co., Ltd.
Christiana Corporate, 200 Continental Drive;
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-347-918-3531
Sales inquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blog | YouTube
Source: Future Market Insights Inc.
View the original press release at accesswire.com
